Blue Marble University Medical School has updated its Curriculum to add a third course in the “new medicine” which is stem cell therapy. Joining the two current courses in the line-up, “Stem Cell Biology”, and “Autologous Stem Cell Therapy”, the new course is entitled:
“Mixed Cell Regenerative Medicine”
The course takes up the 21st Century Cures Act, the law authorizing stem cell treatments in the United States, and along with the two current courses, further develops the student’s understanding of developing stem cell practices in the US, focusing on the fact that most stem cell procedures involved mixed cell types, as well as the new companion therapies involving Platelet Rich Plasma (PRP), platelet growth factors, and use of the Stromal Vascular Fractions. The course was developed by Walter P. Drake, Director of the Panama College of Cell Science, which offers an online PhD program in stem cell biology.
Graduates of the Blue Marble University Medical School will have a full and complete understanding of the many new therapeutic modalities based on adult stem cells and related autologous stem cells harvested from bone marrow, fatty tissue liposates, and peripheral blood.
While the term “Mixed Cell Regenerative Medicine” is a more accurate reflection of the blood fractions being used in therapy in that many types of cells are harvested and used without purification to a single cell type, the traditional term “Stem Cell Therapy” may be hard to replace.
The current line-up of three stem cell courses in the MD curriculum will occupy a full 4 month term and will include:
Stem Cell Biology – The course begins with an overview of stem cells and the early history of embryonic stem cell research. We then proceed to a review of the techniques of using stem cells derived from human fetal tissue, and what diseases can be particularly controlled or cured. The course also includes a review of the current status of human embryonic stem cell treatments, why the international medical community has abandoned its interest in using embryonic stem cells, and also covering the two major drawbacks to embryonic stem cell therapy: Tendency toward proliferation (differentiation), making stem cells almost impossible to control once injected into another body, resulting in a differentiated cell ball of many types referred to as a teratoma; and the problem of cell rejection due to having “foreign” cell membrane antigenic determinants requiring a patient to take immune suppressing drugs.
Autologous Stem Cell Therapy– The course covers international treatments available using autologous stem cells (collected from the patient). The primary international treatment centers are reviewed. The mechanism of action is studied. The purpose of the course is to bring to light the many curative techniques being used internationally, such as the repair of severed spinal cord using neural stem cells isolated from the patients nose. It is hoped that the student can gain insight to the fact that these current international treatments are no longer “hypothetical”, and hopefully will inspire the students to generate their own ideas for future work in their careers.
Mixed Cell Regenerative Medicine and the 21st Century Cures Act-The Law Authorizing Stem Cell Treatments in the United States. The course further develops the student’s understanding of developing practices in the US, focusing on the fact that most stem cell procedures involved mixed cell types, as well as the new companion therapies involving Platelet Rich Plasma (PRP) and Stromal Vascular Fractions (SVF).
Blue Marble University Medical School
3-year Online M.D. Degree
For Use in Non-Clinical Careers